Bioabsorbable Stents Market Strategic Analysis 2019 to 2024 | Expected to Grow xx% CAGR of Top Key Players and Regions


Report Titled: “Bioabsorbable Stents Market – Growth, Trends, and Forecast (2019 – 2024)

The Research Report on “Bioabsorbable Stents Market” 2019 report includes every aspect of the Bioabsorbable Stents industry along with the progress performance. Bioabsorbable Stents Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the Bioabsorbable Stents industry. Additionally, Bioabsorbable Stents Market 2019 research report offers key analysis on the industry status of the Bioabsorbable Stents producers with market size, growth, share, trends as well as business price structure.

The Bioabsorbable Stents Market report is a professional and detailed study on the Bioabsorbable Stents business. Bioabsorbable Stents market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.

Get a Sample Copy of the Report –

Scope of the Report:

  • According to the report, the polymer-based or metal-based stents dissolve or get absorbed in the body, and are expected to overcome complications and risks associated with metallic stents.

    Market Overview:

  • The global bioabsorbable stents market was valued at USD 112.14 million in 2018, and is estimated to be valued at USD 183.28 million in 2024, witnessing a CAGR of 8.53%. Factors that are driving the market include a high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population.
  • As per the report of the World Health Organization (WHO), it is seen that the number one cause of death across the world is cardiovascular disease. Furthermore, the WHO has estimated that in 2016, approximately 17.9 million people died due to cardiovascular diseases (CVDs) which represents 31% of the total global deaths, and 85% of these deaths were due to heart attack and stroke. As reported by the Australian Heart Foundation, cardiovascular disease (CVD) is a major cause of death in Australia, with 43,477 deaths being attributed to CVD in Australia in 2017. Cardiovascular disease kills one Australian every 12 minutes. Hence, this global rise in the prevalence of CVD is expected to fuel the market growth.

    Bioabsorbable Stents Report Also Covers Offer for New Project Includes:

    • Market Entry Strategies
    • Countermeasures of Economic Impact
    • Marketing Channels
    • Feasibility Studies of New Project Investment
    • Research Conclusions of the Bioabsorbable Stents Industry

    The report provides key statistics on the market status of the Bioabsorbable Stents Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Bioabsorbable Stents.

    Enquire Before Purchasing this Report –

    Bioabsorbable Stents Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:

  • Boston Scientific Corporation
  • Arterius Limited
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co. Ltd
  • Terumo Corporation
  • Abbott Laboratories Inc.
  • Amaranth Medical
  • Biotronik
  • Meril Life Sciences Pvt. Ltd
  • Reva Medical

    Key Market Trends:

    Polymer-based Bioabsorbable Stents Sub-segment is Expected to hold its Highest Market Share in the Product Type Segment

    In the product type segment of the market, polymer-based bioabsorbable stents are believed to have the largest market size and are expected to witness a CAGR of 8.95% in the forecast period.

    Bioabsorbable stents (BAS)/polymer-based bioabsorbable stents are made of the materials that can completely dissolve or be absorbed in the body. These are used both in peripheral and coronary artery disease. Most of the bioabsorbable stents are made of polylactic acid that is a naturally dissolvable material. However, the polymer materials, such as polycarbonates, polyesters, corrodible metals, and bacterial-derived polymers are under investigation for developing the next-generation bioabsorbable stents. The risk of the in-stent restenosis using drug-eluting and metallic stents (DES) has raised the need for bioabsorbable stents. The BAS has a low rate of late-stent thrombosis (LST) and restenosis, which led to the acceptance of BAS for clinical purposes. The product Absorb GT1 Bioresorbable Vascular Scaffold System (BVS) from Abbott was the first absorbable stent for coronary artery disease that received FDA in 2016, and was commercially available in Europe from 2011. However, on September 14, 2017, Abbott announced the end of sales of the Absorb bioresorbable vascular scaffold, due to poor sales and safety concerns, which led to a strong negative impact on the market. However, owing to the increased significance of the same, this sub-segment is expected to register substantial growth in the coming future.

    Europe Dominates the Market and is Expected to do the Same in the Forecast Period

    Europe currently dominates the market for bioabsorbable stents and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased usage of bioabsorbable stents. There is a rise in the usage because the region has a large number of people suffering from cardiovascular diseases and there is a huge demand for technologically advanced treatment options for the same.

    Purchase this Report (Price 4250 USD for Single User License) –

    Detailed TOC of Bioabsorbable Stents Market Report are:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Introduction to Market Drivers and Restraints
    4.3 Market Drivers
    4.3.1 High Prevalence of Cardiovascular Diseases Globally
    4.3.2 Steep Increase in Aging Population
    4.3.3 Expanding Base of Obese Population
    4.4 Market Restraints
    4.4.1 Stringent Regulatory Scenario
    4.4.2 High Device Cost
    4.4.3 Safety Issues Related to Bioabsorbable Stents
    4.5 Industry Attractiveness – Porter’s Five Forces Analysis
    4.5.1 Threat of New Entrants
    4.5.2 Bargaining Power of Buyers/Consumers
    4.5.3 Bargaining Power of Suppliers
    4.5.4 Threat of Substitute Products
    4.5.5 Intensity of Competitive Rivalry

    5.1 By Product
    5.1.1 Polymer-based Bioabsorbable Stents
    5.1.2 Metal-based Bioabsorbable Stents
    5.2 By Application
    5.2.1 Coronary Artery Disease
    5.2.2 Peripheral Artery Disease
    5.3 By Absorption Rate
    5.3.1 Slow Absorption Rate
    5.3.2 Fast Absorption Rate
    5.4 By End User
    5.4.1 Hospitals
    5.4.2 Other End Users
    5.5 Geography
    5.5.1 North America United States Canada Mexico
    5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.5.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Boston Scientific Corporation
    6.1.2 Arterius Limited
    6.1.3 Elixir Medical Corporation
    6.1.4 Kyoto Medical Planning Co. Ltd
    6.1.5 Terumo Corporation
    6.1.6 Abbott Laboratories Inc.
    6.1.7 Amaranth Medical
    6.1.8 Biotronik
    6.1.9 Meril Life Sciences Pvt. Ltd
    6.1.10 Reva Medical



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Solar Energy Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2024

    Aerial Tramway Market 2019–Global Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2022

    Capacitor Banks Market 2019 Global Leading Players, Industry Updates, Future Growth, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2025